Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology
dc.contributor.author | Nadarajah, Ramesh | |
dc.contributor.author | Ludman, Peter | |
dc.contributor.author | Laroche, Cécile | |
dc.contributor.author | Appelman, Yolande | |
dc.contributor.author | Brugaletta, Salvatore | |
dc.contributor.author | Budaj, Andrzej | |
dc.contributor.author | Bueno, Héctor | |
dc.contributor.author | Huber, Kurt | |
dc.contributor.author | Kunadian, Vijay | |
dc.contributor.author | Leonardi, Sergio | |
dc.contributor.author | Lettino, Maddalena | |
dc.contributor.author | Milasinovic, Dejan | |
dc.contributor.author | Gale, Chris P. | |
dc.contributor.author | Moreno Muñoz, Guillermo | |
dc.contributor.author | NSTEMI (grupo de investigación) | |
dc.date.accessioned | 2024-10-29T19:10:36Z | |
dc.date.available | 2024-10-29T19:10:36Z | |
dc.date.issued | 2023-02-03 | |
dc.description.abstract | Background: The majority of NSTEMI burden resides outside high-income countries (HICs). We describe presentation, care, and outcomes of NSTEMI by country income classification. Methods and results: Prospective cohort study including 2947 patients with NSTEMI from 287 centres in 59 countries, stratified by World Bank country income classification. Quality of care was evaluated based on 12 guideline-recommended care interventions. The all-or-none scoring composite performance measure was used to define receipt of optimal care. Outcomes included in-hospital acute heart failure, stroke/transient ischaemic attack, and death, and 30-day mortality. Patients admitted with NSTEMI in low to lower-middle-income countries (LLMICs), compared with patients in HICs, were younger, more commonly diabetic, and current smokers, but with a lower burden of other comorbidities, and 76.7% met very high risk criteria for an immediate invasive strategy. Invasive coronary angiography use increased with ascending income classification (LLMICs, 79.2%; upper middle income countries [UMICs], 83.7%; HICs, 91.0%), but overall care quality did not (≥80% of eligible interventions achieved: LLMICS, 64.8%; UMICs 69.6%; HICs 55.1%). Rates of acute heart failure (LLMICS, 21.3%; UMICs, 12.1%; HICs, 6.8%; P < 0.001), stroke/transient ischaemic attack (LLMICS: 2.5%; UMICs: 1.5%; HICs: 0.9%; P = 0.04), in-hospital mortality (LLMICS, 3.6%; UMICs: 2.8%; HICs: 1.0%; P < 0.001) and 30-day mortality (LLMICs, 4.9%; UMICs, 3.9%; HICs, 1.5%; P < 0.001) exhibited an inverse economic gradient. Conclusion: Patients with NSTEMI in LLMICs present with fewer comorbidities but a more advanced stage of acute disease, and have worse outcomes compared with HICs. A cardiovascular health narrative is needed to address this inequity across economic boundaries. | en |
dc.description.department | Depto. de Enfermería | |
dc.description.faculty | Fac. de Enfermería, Fisioterapia y Podología | |
dc.description.refereed | TRUE | |
dc.description.sponsorship | Abbott Vascular Int | |
dc.description.sponsorship | Amgen Cardiovascular | |
dc.description.sponsorship | AstraZeneca | |
dc.description.sponsorship | Bayer AG | |
dc.description.sponsorship | Boehringer Ingelheim | |
dc.description.sponsorship | Boston Scientific | |
dc.description.sponsorship | the Bristol Myers Squibb and Pfizer Alliance | |
dc.description.sponsorship | Daiichi Sankyo Europe GmbH | |
dc.description.sponsorship | the Alliance Daiichi Sankyo Europe GmbH and Eli Lilly and Company | |
dc.description.sponsorship | Edwards | |
dc.description.sponsorship | Gedeon Richter Plc | |
dc.description.sponsorship | Menarini Int. Op | |
dc.description.sponsorship | MSD-Merck & Co | |
dc.description.sponsorship | Novartis Pharma AG | |
dc.description.sponsorship | ResMed | |
dc.description.sponsorship | Sanofi | |
dc.description.sponsorship | Servier | |
dc.description.sponsorship | Vifor | |
dc.description.status | pub | |
dc.identifier.citation | Nadarajah R, Ludman P, Laroche C, Appelman Y, Brugaletta S, Budaj A, et al. Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology. European Heart Journal - Quality of Care and Clinical Outcomes. 2023;9(6):552-63. | |
dc.identifier.doi | 10.1093/ehjqcco/qcad008 | |
dc.identifier.issn | 2058-5225 | |
dc.identifier.issn | 2058-1742 | |
dc.identifier.officialurl | https://doi.org/10.1093/ehjqcco/qcad008 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14352/109752 | |
dc.issue.number | 6 | |
dc.journal.title | European Heart Journal - Quality of Care and Clinical Outcomes | |
dc.language.iso | eng | |
dc.page.final | 563 | |
dc.page.initial | 552 | |
dc.publisher | Oxford Academic | |
dc.rights | Attribution-NonCommercial 4.0 International | en |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | |
dc.subject.cdu | 616.12 | |
dc.subject.keyword | NSTEMI Registry | |
dc.subject.keyword | Country income | |
dc.subject.keyword | Quality indicators | |
dc.subject.keyword | Mortality | |
dc.subject.ucm | Cardiología | |
dc.subject.unesco | 3205.01 Cardiología | |
dc.title | Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology | en |
dc.type | journal article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 9 | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 907be5df-d04d-42bd-9427-258b71326fb6 | |
relation.isAuthorOfPublication.latestForDiscovery | 907be5df-d04d-42bd-9427-258b71326fb6 |
Download
Original bundle
1 - 1 of 1
Loading...
- Name:
- Presentation_care_and_outcomes.pdf
- Size:
- 1.13 MB
- Format:
- Adobe Portable Document Format